Targeting nuclear import and export in hematological malignancies

B Nachmias, AD Schimmer - Leukemia, 2020 - nature.com
The transport of proteins across the nuclear membrane is a highly regulated process,
essential for the cell function. This transport is actively mediated by members of the …

Nucleophosmin in its interaction with ligands

I Cela, A Di Matteo, L Federici - International journal of molecular sciences, 2020 - mdpi.com
Nucleophosmin (NPM1) is a mainly nucleolar protein that shuttles between nucleoli,
nucleoplasm and cytoplasm to fulfill its many functions. It is a chaperone of both nucleic …

[HTML][HTML] Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance

KB Emdal, N Palacio-Escat, C Wigerup, A Eguchi… - Cell Reports, 2022 - cell.com
Acute myeloid leukemia (AML) is a heterogeneous disease with variable patient responses
to therapy. Selinexor, an inhibitor of nuclear export, has shown promising clinical activity for …

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

KH Lin, JC Rutter, A Xie, ST Killarney, C Vaganay… - Nature cancer, 2022 - nature.com
Selinexor is a first-in-class inhibitor of the nuclear exportin XPO1 that was recently approved
by the US Food and Drug Administration for the treatment of multiple myeloma and diffuse …

PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer

A Salvi, AN Young, AC Huntsman, MR Pergande… - Cell death & …, 2022 - nature.com
PHY34 is a synthetic small molecule, inspired by a compound naturally occurring in tropical
plants of the Phyllanthus genus. PHY34 was developed to have potent in vitro and in vivo …

Hyponatremia in patients with hematologic diseases

E Koumpis, M Florentin, E Hatzimichael… - Journal of Clinical …, 2020 - mdpi.com
Hyponatremia is the most common electrolyte disorder in clinical practice and is associated
with increased morbidity and mortality. It is frequently encountered in hematologic patients …

Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma

P Thirasastr, N Somaiah - Therapeutic Advances in Medical …, 2022 - journals.sagepub.com
Liposarcoma (LPS) is a common soft tissue sarcoma that encompasses diverse subtypes of
well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic LPS. There is …

High throughput fluorescence-based in vitro experimental platform for the identification of effective therapies to overcome tumour microenvironment-mediated drug …

Y Arroyo-Berdugo, M Sendino, D Greaves… - Cancers, 2023 - mdpi.com
Simple Summary The interactions between Acute Myeloid Leukaemia (AML) cells and the
surrounding bone marrow (BM) tissue contribute to blocking the efficacy of current drug …

Selinexor, selective inhibitor of nuclear export: Unselective bullet for blood cancers

K Benkova, J Mihalyova, R Hajek, T Jelinek - Blood Reviews, 2021 - Elsevier
Abstract Exportin 1 (XPO1), also known as chromosome maintenance 1 protein (CRM1), is
the main transporter for hundreds of proteins like tumor suppressors, growth regulatory …

A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients

MP Martínez Sánchez, JE Megías-Vericat… - Annals of …, 2021 - Springer
Prognosis for relapsed or refractory (R/R) acute myeloid leukemia (AML) despite salvage
therapy is dismal. This phase I dose-escalation trial assessed the safety and preliminary …